Iliac Stent Market Sees Shift Toward High-Precision Stent Placement Devices and Endovascular Techniques

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Iliac Stent Market- (Type (Self-expandable Stents, Balloon-expandable Stents and Others), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesion and Complete Obstructive Lesions), By End-use (Hospitals, Outpatient Facilities and Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Iliac Stent Market is valued at US$ 1.02 Bn in 2023, and it is expected to reach US$ 1.61 Bn by 2031, with a CAGR of 6.07% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2416

An iliac stent is a medical device constructed from a mesh of stainless steel, specifically designed for insertion into the iliac artery-an essential vascular structure in the pelvic region responsible for delivering blood to the lower limbs. In patients diagnosed with cardiovascular disorders such as atherosclerosis, the primary purpose of iliac stent deployment is to alleviate arterial stenosis or obstruction and restore optimal blood circulation.

The increasing demand for iliac stents is driven by several factors, including a rising preference for minimally invasive treatment modalities, a growing incidence of peripheral artery disease (PAD), and continual advancements in stent design and biomaterials. These innovations have significantly enhanced clinical outcomes, thereby accelerating adoption rates. Additionally, increased awareness among healthcare providers and patients regarding the clinical benefits of iliac stenting over alternative interventions is further supporting market expansion.

Nonetheless, the market encounters certain constraints, including stringent regulatory compliance requirements and the availability of alternative treatment options, which may hinder growth to some extent. Despite these limitations, the market outlook remains positive, supported by an aging global population with a higher susceptibility to peripheral vascular disorders, increased investments in healthcare infrastructure, a rising number of skilled interventional specialists, strategic initiatives by pharmaceutical companies, and greater public awareness of advanced therapeutic solutions.

List of Prominent Players in the Iliac Stent Market:
• BD
• Abbott
• Boston Scientific Corporation
• W. L. Gore & Associates, Inc.
• Medtronic
• Cook
• Terumo Corporation
• iVascular
• Getinge AB
• Biotronik SE & Co KG

Market Dynamics:
Drivers-
The global stent industry serves as a key catalyst for the expansion of the iliac stent market, driven by multiple critical factors such as the rising preference for minimally invasive surgical interventions, continuous innovations in medical device technologies, and the increasing global incidence of cardiovascular diseases. Collectively, these elements are instrumental in propelling market growth.

Self-expanding stents, in particular, represent a significant segment of the market owing to their proven efficacy in the treatment of external iliac artery conditions. Furthermore, growth is being reinforced by strategic initiatives undertaken by prominent industry players, including the introduction of innovative product lines, successful regulatory approvals, and heightened efforts to raise awareness about peripheral artery disease. These actions are contributing to the rapid advancement and adoption of iliac stent solutions across global healthcare systems.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Challenges:
The iliac stent market is confronted with several challenges that may restrain its growth trajectory. Chief among these are the availability of alternative cardiovascular therapies, stringent regulatory frameworks, and the inherent complexities of angioplasty procedures. The existence of other treatment modalities may dissuade patients and clinicians from selecting stent implantation as a preferred option. Furthermore, issues such as product recalls and procedural complications during stent deployment may undermine market confidence and hinder adoption. The regulatory approval process also presents a significant barrier, as rigorous compliance standards can delay the market entry of new and advanced stent technologies, limiting innovation and slowing overall market development.

Regional Trends:
North America is expected to retain a leading position in the global iliac stent market, driven by a high prevalence of peripheral artery disease, increased public health awareness, strong governmental healthcare initiatives, and continuous advancements in medical technology. The region benefits from a well-established healthcare infrastructure and the presence of key market players, particularly in the United States, where the aging population and growing incidence of vascular disorders are further accelerating market demand.

Europe also represents a substantial portion of the global market, supported by the increasing number of vascular procedures, sustained investment in medical device innovation, and supportive government healthcare programs. The region's growing preference for minimally invasive endovascular procedures continues to contribute to the expansion of the iliac stent market across multiple European countries.

Recent Developments:
• In January 2024, Abbott announced the launch of NavitorTM, their next-generation transcatheter aortic valve implantation (TAVI) system. This minimally invasive technology will now be accessible to patients in India who suffer from severe aortic stenosis and are deemed to be at high or extreme risk for surgery. The Navitor TAVI system is the newest offering from the company's extensive structural heart transcatheter portfolio, providing patients and doctors with less invasive alternatives for treating heart disorders.
• In February 2024, BD and the world's foremost manufacturer of laboratory automation technology, Hamilton, announced a partnership to create robotics-compatible reagent kits and automated applications that allow larger-scale single-cell multi-omics experiments to be conducted with more precision and less room for human error.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2416

Segmentation of Iliac Stent Market-
Iliac Stent Market-By Type
• Self-expandable Stents
• Balloon-expandable Stents
• Others
Iliac Stent Market-By Artery Lesions
• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions
Iliac Stent Market-By End-Use
• Hospitals
• Outpatient Facilities
• Others
Iliac Stent Market-By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/iliac-stents-market/2416

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.